Cargando…
Changes of Amide Proton Transfer Imaging in Multiple System Atrophy Parkinsonism Type
Multiple system atrophy (MSA), an atypical parkinsonism of alpha-synucleinopathies, has no specific biomarker of diagnosis. According to different combinations of symptoms, MSA can be classified as parkinsonism-type MSA (MSA-P) and cerebellar-type MSA (MSA-C; Watanabe et al., 2018). Amide proton tra...
Autores principales: | Li, Shuhua, Chan, Piu, Li, Chunmei, Chen, Haibo, Chen, Min, Su, Wen, Li, Kai, Lu, Na, Yu, Lu, Chu, Defa, Wu, Pu-Yeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556302/ https://www.ncbi.nlm.nih.gov/pubmed/33192464 http://dx.doi.org/10.3389/fnagi.2020.572421 |
Ejemplares similares
-
Evolution of Cerebral Ischemia Assessed by Amide Proton Transfer-Weighted MRI
por: Song, Guodong, et al.
Publicado: (2017) -
Amide Proton Transfer MRI Signal as a Surrogate Biomarker of Ischemic Stroke Recovery in Patients With Supportive Treatment
por: Yu, Lu, et al.
Publicado: (2019) -
Magnetization Transfer and Amide Proton Transfer MRI of Neonatal Brain Development
por: Zheng, Yang, et al.
Publicado: (2016) -
Chemical Exchange Saturation Transfer MRI Signal Loss of the Substantia Nigra as an Imaging Biomarker to Evaluate the Diagnosis and Severity of Parkinson's Disease
por: Li, Chunmei, et al.
Publicado: (2017) -
Total Cerebral Small Vessel Score Association With Hoehn and Yahr Stage in Parkinson’s Disease
por: Ma, Xinxin, et al.
Publicado: (2021)